Molecular Mechanisms of Prostate Cancer Development in the Precision Medicine Era: A Comprehensive Review
Cancers · 25.01.2024 · 16 (3) · 523
DOI: 10.3390/cancers16030523 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 25.01.2024. Verfasst von Shigekatsu Maekawa und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Iwate Medical University, Iwate 028-3694, Japan. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 338 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The progression of prostate cancer (PCa) relies on the activation of the androgen receptor (AR) by androgens. Despite efforts to block this pathway through androgen deprivation therapy, resistance can occur through several mechanisms, including the abnormal activation of AR, resulting in castration-resistant PCa following the introduction of treatment. Mutations, amplifications, and splicing variants in AR-related genes have garnered attention in this regard. Furthermore, recent large-scale next-generation sequencing analysis has revealed the critical roles of AR and AR-related genes, as well as the DNA repair, PI3K, and cell cycle pathways, in the onset and progression of PCa. Moreover, research on epigenomics and microRNA has increasingly become popular; however, it has not translated into the development of effective therapeutic strategies. Additionally, treatments targeting homologous recombination repair mutations and the PI3K/Akt pathway have been developed and are increasingly accessible, and multiple clinical trials have investigated the efficacy of immune checkpoint inhibitors. In this comprehensive review, we outline the status of PCa research in genomics and briefly explore potential future developments in the field of epigenetic modifications and microRNAs.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Iwate Medical University, Iwate 028-3694, Japan.
ORCID-Profile: Shigekatsu Maekawa, Ryo Takata
Zitieren
APA
Maekawa, S., Takata, R., & Obara, W. (2024). Molecular Mechanisms of Prostate Cancer Development in the Precision Medicine Era: A Comprehensive Review. Cancers, 16(3), 523. https://doi.org/10.3390/cancers16030523
Vancouver
Maekawa S, Takata R, Obara W. Molecular Mechanisms of Prostate Cancer Development in the Precision Medicine Era: A Comprehensive Review. Cancers. 2024;16(3):523. doi:10.3390/cancers16030523
BibTeX
@article{Maekawa2024,
author = {Maekawa, Shigekatsu and Takata, Ryo and Obara, Wataru},
title = {Molecular Mechanisms of Prostate Cancer Development in the Precision Medicine Era: A Comprehensive Review},
journal = {Cancers},
year = {2024},
volume = {16},
number = {3},
pages = {523},
doi = {10.3390/cancers16030523}
}
EUVIMED